JP2025501414A5 - - Google Patents
Info
- Publication number
- JP2025501414A5 JP2025501414A5 JP2024561738A JP2024561738A JP2025501414A5 JP 2025501414 A5 JP2025501414 A5 JP 2025501414A5 JP 2024561738 A JP2024561738 A JP 2024561738A JP 2024561738 A JP2024561738 A JP 2024561738A JP 2025501414 A5 JP2025501414 A5 JP 2025501414A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- nitric oxide
- ino
- dose
- ibw
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263296359P | 2022-01-04 | 2022-01-04 | |
| US63/296,359 | 2022-01-04 | ||
| US202263341986P | 2022-05-13 | 2022-05-13 | |
| US63/341,986 | 2022-05-13 | ||
| US202263342535P | 2022-05-16 | 2022-05-16 | |
| US63/342,535 | 2022-05-16 | ||
| PCT/US2023/060080 WO2023133399A1 (en) | 2022-01-04 | 2023-01-04 | Use of inhaled nitric oxide (ino) for treating patients with pulmonary hypertension associated with sarcoidosis (ph-sarc) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501414A JP2025501414A (ja) | 2025-01-17 |
| JP2025501414A5 true JP2025501414A5 (https=) | 2026-01-08 |
Family
ID=87074247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024561738A Pending JP2025501414A (ja) | 2022-01-04 | 2023-01-04 | サルコイドーシスに関連する肺高血圧症（ＰＨ－ＳＡＲＣ）を有する患者を治療するための一酸化窒素吸入療法（ｉＮＯ）の使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250302869A1 (https=) |
| EP (1) | EP4460369A4 (https=) |
| JP (1) | JP2025501414A (https=) |
| KR (1) | KR20240145466A (https=) |
| CN (1) | CN119095604A (https=) |
| AU (1) | AU2023205912A1 (https=) |
| CA (1) | CA3242496A1 (https=) |
| MX (1) | MX2024008126A (https=) |
| TW (1) | TW202345876A (https=) |
| WO (1) | WO2023133399A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150272988A1 (en) * | 2012-03-07 | 2015-10-01 | Advanced Inhalation Therapies (Ait) Ltd. | Inhalation of nitric oxide for treating respiratory diseases |
| TR201707036T4 (en) * | 2012-12-04 | 2018-11-21 | Ino Therapeutics Llc | Cannula to minimize dose dilution during administration of nitric oxide |
| JP2021509109A (ja) * | 2017-12-28 | 2021-03-18 | ベレロフォン パルス テクノロジーズ エルエルシー | 肺高血圧症の治療のための吸入用一酸化窒素のパルス投与 |
| WO2019222640A1 (en) * | 2018-05-17 | 2019-11-21 | Bellerophon Therapeutics | Method and apparatus for pulsatile delivery of nitric oxide |
| WO2020142658A1 (en) * | 2019-01-04 | 2020-07-09 | Bellerophon Therapeutics | Use of inhaled nitric oxide (ino) for improving activity levels in patients with lung-related conditions |
-
2023
- 2023-01-04 CN CN202380025284.7A patent/CN119095604A/zh active Pending
- 2023-01-04 WO PCT/US2023/060080 patent/WO2023133399A1/en not_active Ceased
- 2023-01-04 AU AU2023205912A patent/AU2023205912A1/en active Pending
- 2023-01-04 US US18/726,314 patent/US20250302869A1/en active Pending
- 2023-01-04 MX MX2024008126A patent/MX2024008126A/es unknown
- 2023-01-04 TW TW112100225A patent/TW202345876A/zh unknown
- 2023-01-04 EP EP23737708.0A patent/EP4460369A4/en active Pending
- 2023-01-04 JP JP2024561738A patent/JP2025501414A/ja active Pending
- 2023-01-04 CA CA3242496A patent/CA3242496A1/en active Pending
- 2023-01-04 KR KR1020247025756A patent/KR20240145466A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Colebatch et al. | Effect of vagotomy and vagal stimulation on lung mechanics and circulation | |
| AU2018394928B2 (en) | Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension | |
| Mutoh et al. | Cardiopulmonary effects of sevoflurane, compared with halothane, enflurane, and isoflurane, in dogs | |
| JP7813138B2 (ja) | 肺に関連する状態を有する患者における活動レベルを改善するための一酸化窒素吸入療法（ｉＮＯ）の使用 | |
| Klausen et al. | Acute effects of cigarette smoking and inhalation of carbon monoxide during maximal exercise | |
| Stock et al. | The PaCO2 rate of rise in anesthetized patients with airway obstruction | |
| KR20010005502A (ko) | 수술 후에 환자로부터 증기 마취제를 제거하는 방법 | |
| Glenn et al. | Diaphragm pacing: application to a patient with chronic obstructive pulmonary disease | |
| US20130302445A1 (en) | Apparatus and method for treating cerebral ischemia using non-inhaled carbon dioxide | |
| Walpole et al. | Effect of sevoflurane concentration on inhalation induction of anaesthesia in the elderly | |
| EP2825179B1 (en) | Methods of administering high concentrations of nitric oxide | |
| Joad et al. | Nitric oxide contributes to substance P-induced increases in lung rapidly adapting receptor activity in guinea-pigs | |
| Mutoh et al. | Effects of medetomidine-midazolam, midazolambutorphanol, or acepromazine-butorphanol as premedicants for mask induction of anesthesia with sevoflurane in dogs | |
| JP2025501414A5 (https=) | ||
| Brundin et al. | Effect of intermittent positive pressure ventilation on cardiac systolic time intervals | |
| RU2839350C1 (ru) | Способ коррекции кислородной зависимости при сохраненном спонтанном дыхании | |
| Sullivan et al. | Ventilatory response during CO2 inhalation after airway anesthesia with lidocaine | |
| SU1124970A1 (ru) | Способ лечени гипотонической болезни | |
| HK40127956A (zh) | 吸入性一氧化氮和氧气用於治疗肺高压症的用途 | |
| RU2203691C2 (ru) | Способ профилактики и лечения заболеваний, в том числе вызванных изменениями климатических условий, неблагоприятными факторами среды обитания, особенно повышенным содержанием углекислого газа, с использованием эндогенного дыхания | |
| JP2025501414A (ja) | サルコイドーシスに関連する肺高血圧症（ＰＨ－ＳＡＲＣ）を有する患者を治療するための一酸化窒素吸入療法（ｉＮＯ）の使用 | |
| Tammesto et al. | The role of thiopental and fentanyl in the production of balanced anaesthesia | |
| Gasthuys et al. | Time‐related responses to a constant‐dose halothane anaesthesia in dorsally recumbent ventilated ponies | |
| Hubbell et al. | Management of intravenous anesthesia to control recovery time | |
| Lal et al. | Oxygen administration after myocardial infarction |